Non-response to omalizumab in patients with chronic spontaneous urticaria (CSU): A 10-year real-world UK study

Smith, H., Denman, S., Arumugakani, G. et al. (2 more authors) (2023) Non-response to omalizumab in patients with chronic spontaneous urticaria (CSU): A 10-year real-world UK study. In: Clinical & Experimental Allergy. BSACI Annual Conference 2023, 05-07 Oct 2023, Harrogate, UK. Wiley , p. 1082.

Metadata

Authors/Creators:
Dates:
  • Published: 19 September 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 29 Jan 2024 11:17
Last Modified: 29 Jan 2024 11:17
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/cea.14393

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)